Yüklüyor......
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Abciximab is a widely studied glycoprotein IIb/IIIa inhibitor, specifically in the setting of patients undergoing percutaneous coronary intervention (PCI). The populations studied have included patients with non-ST-segment acute coronary syndromes, ST-segment elevation myocardial infarction, and ele...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835553/ https://ncbi.nlm.nih.gov/pubmed/20234778 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|